← Back to opportunities
pharmaceuticalsregulatory_compliancehealthcare_logisticsdistributionfraud_preventionIndiaserviceMedium EffortScore 4.8
GLP-1 Drug Distribution Compliance & Logistics Service
Signal Intelligence
1
Sources
📌 Emerging
Signal
2026-03-28
First Seen
2026-03-28
Last Seen
🔁 RESURFACING SIGNAL
2026-03-28→
The Opportunity
Indian regulators are stepping up oversight of GLP-1 drug distribution chains to combat fraud. Pharmaceutical distributors and clinics need help navigating new compliance rules, documentation, and supply chain tracking — but most lack in-house expertise. This is a gap where a compliance and logistics advisory service can help them stay legal and avoid penalties.
Market Size₹400-600 Cr addressable market annually — covering 5,000+ clinics, diagnostic centres, and pharmaceutical distributors across India managing GLP-1 medications
Why NowGST registration (5% on service tax), FSSAI advisory certification if handling food+health nexus, no specific pharmaceutical license needed if you're advising (not distributing).
Loading…